Compartmentation and intracellular traffic of mRNPs
In eukaryotic cells, cytoplasmic mRNAs can be
translated, degraded or stored, depending on the proteins that are bound to
them. These proteins mediate a variety of post-transcriptional regulation pathways,
which are essential for many aspects of cell physiology. Remarkably, many
implicated factors and their target mRNAs accumulate in cytoplasmic membrane-less
ribonucleoprotein (RNP) granules: P-bodies, stress granules, germ
granules, neuronal granules, etc. These granules are also
called condensates, as they form
following liquid-liquid phase separation. Despite names, morphologies and molecular
composition being different depending on the model organism, the cell type and
the environmental conditions, all these granules contain repressed mRNAs. Our
main goal is to understand how the molecular, cellular and physiological
functions of these condensates differ from the functions of identical mRNPs diffuse
in the cytoplasm. We want to decipher how
do these granules assemble? What are their protein and RNA content and the
dynamics of such content? What is their function in RNA metabolism, and more broadly
in cell physiology?
We tackle these questions using a combination of experimental approaches
including biochemical and cell imaging techniques, as well as proteomic and
transcriptomic analyses. Most of our studies focus on P-bodies in
human cells [1].
- How do they assemble? We have shown that three proteins are required for P-body
assembly in human cells: the RNA helicase DDX6 and its partners LSM14A and 4E-T
[2-5]. However, further progressing on the assembly mechanisms is limited by
the high complexity of P-body composition (a hundred of proteins and thousands
mRNAs). We therefore also turned to a synthetic biology approach, allowing us
to study artificial granules that are made of a limited and controlled number
of proteins and RNAs (collaboration with Zoher Gueroui, ENS Chimie). As a
result we have shown how RNA at the surface of condensates impacts their
number, their size and their physical properties [6,7]
- What is their protein and RNA
content? What is their
function in RNA metabolism? We have pioneered a method to purify P-bodies from cells, called
Fluorescence Activated Particle Sorting (FAPS). This allowed us to
identify their protein and RNA content by mass spectrometry and RNAseq,
respectively. Their analysis, combined with polysome profiling experiments and in silico investigations, led us to draw
two major conclusions: P-bodies store a large diversity of RNAs, most of them
are coding but inefficiently translated, and they code for proteins with
regulatory functions [1,8,9]; the mRNA GC-content is key to their localization
in P-bodies (P-bodies only contain AU-rich mRNAs) and to post-transcriptional
regulation in general (translation repression, mRNA decay pathways) [10,11].
This kind of approach opens up the possibility to investigate the dynamics of the P-body content in
different conditions, diverse cellular environments and various cell types.
-
What is their function in cell physiology? Established cell lines grow
well in the absence of DDX6 expression, and therefore in the absence of
P-bodies. However, in human, several heterozygous mutations in the DDX6 gene
are responsible for mental retardation associated to neurodevelopmental
defects. We have shown that the DDX6 mutations lead to a strong P-body defect
in the patient cells, as well as to some mRNA post-transcriptional deregulation
[12,13]. These findings constitute a unique entry point to understand the
function of P-bodies and/or DDX6 during development.
Poster flash talk (5 min)
|
Poster presentation during the virtual meeting CSHL Translational Control
(Sept. 2020)
|
Lecture (1h30)
|
Lecture about mRNA cytoplasmic metabolism in mammalian cells for Master 1 students (in french)
(Feb. 2019)
|
1 Standart, N. and Weil, D. (2018) Trends Genet. 34, 612–626
2 Ayache, J. et al. (2015)
Mol. Biol. Cell 26, 2579–2595
3 Kamenska, A. et al. (2016) Nucleic Acids Res. 44, 6318–6334
4 Vindry, C. et al. (2017)
Cell Rep. 20, 1187–1200
5 Chauderlier, A. et al. (2018)
Biochim. Biophys. Acta 1861, 762–772
6 Garcia-Jove Navarro, M. et al. (2019)
Nat. Commun. 10, 3230
7 Cochard, A. et al. (2022)
Biophys. J. 121, 1675-1690
8 Hubstenberger, A. et al. (2017)
Mol. Cell 68, 144-157.e5
9 Courel, M. et al. (2018)
Med. Sci. MS 34, 306–308
10 Courel, M. et al. (2019)
eLife 8:e49708
11 Vindry, C. et al. (2019)
Wiley Interdiscip. Rev. RNA 10(6):e1557
12 Balak, C. et al. (2019) Am. J. Hum. Genet. 105, 509-525
13 Weil et al. (2020)
Biochem. Soc. Trans. 48, 1199-1211
Collaborations
- Edouard
Bertrand: IGMM, Montpellier, France
- Nadège
Bondurand: Institut Imagine, Paris, France
- Daniel Gautheret: I2BC Saclay, France
- Zoher
Gueroui: ENS Paris, France
- Judith
Miné-Hattab: LCQB, IBPS
- Gérard
Pierron: Institut Gustave Roussy, Villejuif, France
- Amélie Piton: IGBMC, Strasbourg, France
- Hugues
Roest Crollius: ENS Paris, France
- Nancy Standart: University of Cambridge, UK
- Izabela Sumara: IGBMC, Strasbourg, France